GSK2190915 sodium salt - CAS 1196070-26-4
Catalog number:
1196070-26-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C38H42N3NaO4S
Molecular Weight:
659.81
COA:
Inquire
Targets:
FLAP
Description:
GSK2190915(AM-803; Fiboflapon) sodium salt is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
GSK-2190915A; Fiboflapon sodium; AM-803 sodium
MSDS:
Inquire
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related FLAP Products


CAS 1196070-26-4 GSK2190915 sodium salt

GSK2190915 sodium salt
(CAS: 1196070-26-4)

GSK2190915(AM-803; Fiboflapon) sodium salt is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.

CAS 936350-00-4 GSK2190915

GSK2190915
(CAS: 936350-00-4)

GSK2190915 is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor. It exhibits excellent preclinical toxicology and pharmacokinetics in rat and dog. It a...

CAS 128253-31-6 BAY-X-1005

BAY-X-1005
(CAS: 128253-31-6)

BAY-X 1005 is a potent and selective FLAP (5-lipoxygenase-activating protein) inhibitor. BAY-X 1005 is also a selective inhibitor of leukotriene synthesis. BAY-...

CAS 147030-01-1 MK591

MK591
(CAS: 147030-01-1)

Quiflapon is a synthetic compound which specifically inhibits the activity of 5-Lox and is currently under development for the treatment of asthma. Also, Quifla...

CAS 1206880-66-1 AM679

AM679
(CAS: 1206880-66-1)

AM679 is a drug which acts as a selective inhibitor of 5-Lipoxygenase-activating protein (FLAP). This protein is involved in the production of cysteinyl leukotr...

CAS 136668-42-3 MK-0591

MK-0591
(CAS: 136668-42-3)

Quiflapon is a synthetic compound which specifically inhibits the activity of 5-Lox and is currently under development for the treatment of asthma. Also, Quifla...

Chemical Structure

CAS 1196070-26-4 GSK2190915 sodium salt

Quick Inquiry

Verification code

Featured Items